Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Vascular endothelial growth factor in patients with psoriatic arthritis.

Fink AM, Cauza E, Hassfeld W, Dunky A, Bayer PM, Jurecka W, Steiner A.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):305-8.

PMID:
17543159
2.

The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity.

Machold KP, Köller MD, Pflugbeil S, Zimmermann C, Wagner E, Stuby U, Aletaha D, Stamm TA, Mayrhofer F, Dunky A, Hermann J, Ilias W, Smolen JS.

Ann Rheum Dis. 2007 May;66(5):697-9. Epub 2007 Jan 4.

3.

[Psoriatic arthritis].

Cauza E, Dunky A.

Wien Med Wochenschr. 2006 Nov;156(21-22):587-95. Review. German.

PMID:
17160376
4.

The metabolic effects of long term exercise in Type 2 Diabetes patients.

Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P.

Wien Med Wochenschr. 2006 Sep;156(17-18):515-9.

PMID:
17041809
5.

Clinical aspects of combined cyclosporin a and leflunomide therapy in rheumatoid arthritis.

Haberhauer G, Feyertag J, Dunky A.

J Clin Rheumatol. 2002 Dec;8(6):362-3. No abstract available.

PMID:
17041412
6.

Short-term infliximab therapy improves symptoms of psoriatic arthritis and decreases concentrations of cartilage oligomeric matrix protein.

Cauza E, Hanusch-Enserer U, Frischmuth K, Fabian B, Dunky A, Kostner K.

J Clin Pharm Ther. 2006 Apr;31(2):149-52.

PMID:
16635048
7.

Serum levels of cartilage oligomeric matrix protein (COMP): a rapid decrease in patients with active rheumatoid arthritis undergoing intravenous steroid treatment.

Skoumal M, Haberhauer G, Feyertag J, Kittl EM, Bauer K, Dunky A.

Rheumatol Int. 2006 Sep;26(11):1001-4. Epub 2006 Feb 17.

PMID:
16485108
8.

Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system.

Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P.

Eur J Clin Invest. 2005 Dec;35(12):745-51.

PMID:
16313250
9.

Continuous glucose monitoring in diabetic long distance runners.

Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Kostner K, Dunky A, Haber P.

Int J Sports Med. 2005 Nov;26(9):774-80.

PMID:
16237624
10.

Atypical axial osteomalacia: report of a HLA-B27 negative elderly female patient without features of sacroiliitis.

Haberhauer G, Skoumal M, Dunky A.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5):726-7. No abstract available.

PMID:
16173260
11.

Increased C282Y heterozygosity in gestational diabetes.

Cauza E, Hanusch-Enserer U, Bischof M, Spak M, Kostner K, Tammaa A, Dunky A, Ferenci P.

Fetal Diagn Ther. 2005 Sep-Oct;20(5):349-54.

PMID:
16113552
12.

The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus.

Cauza E, Hanusch-Enserer U, Strasser B, Ludvik B, Metz-Schimmerl S, Pacini G, Wagner O, Georg P, Prager R, Kostner K, Dunky A, Haber P.

Arch Phys Med Rehabil. 2005 Aug;86(8):1527-33.

PMID:
16084803
13.

HFE genotyping demonstrates a significant incidence of hemochromatosis in undifferentiated arthritis.

Cauza E, Hanusch-Enserer U, Etemad M, Köller M, Kostner K, Georg P, Dunky A, Ferenci P.

Clin Exp Rheumatol. 2005 Jan-Feb;23(1):7-12.

PMID:
15789881
14.

Effects of LDL-immunoapheresis on plasma concentrations of vitamin E and carotenoids in patients with familial hypercholesterolemia.

Cauza E, Jansen M, Resch U, Dunky A, Derfler K, Winklhofer-Roob BM, Kostner K.

J Clin Apher. 2004;19(4):174-9.

PMID:
15597350
15.

N-terminal pro-B-type natriuretic peptide as an indicator of possible cardiovascular disease in severely obese individuals: comparison with patients in different stages of heart failure.

Hermann-Arnhof KM, Hanusch-Enserer U, Kaestenbauer T, Publig T, Dunky A, Rosen HR, Prager R, Köller U.

Clin Chem. 2005 Jan;51(1):138-43. Epub 2004 Nov 18.

PMID:
15550477
16.

Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.

Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.

J Clin Pharm Ther. 2004 Oct;29(5):431-6. Erratum in: J Clin Pharm Ther. 2005 Feb;30(1):96. Hanusch-Enserer, H [corrected to Hanusch-Enserer, U].

PMID:
15482386
17.

Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding.

Hanusch-Enserer U, Cauza E, Brabant G, Dunky A, Rosen H, Pacini G, Tüchler H, Prager R, Roden M.

J Clin Endocrinol Metab. 2004 Jul;89(7):3352-8.

PMID:
15240614
19.

Improvement of insulin resistance and early atherosclerosis in patients after gastric banding.

Hanusch-Enserer U, Cauza E, Spak M, Endler G, Dunky A, Tura A, Wagner O, Rosen HR, Pacini G, Prager R.

Obes Res. 2004 Feb;12(2):284-91.

20.

[Methotrexate therapy in rheumatologic diseases--an update].

Cauza E, Dunky A.

Wien Med Wochenschr. 2003;153(13-14):291-4. Review. German.

PMID:
12924103
21.

Relationship of non-LDL-bound apo(a), urinary apo(a) fragments and plasma Lp(a) in patients with impaired renal function.

Cauza E, Kletzmaier J, Bodlaj G, Dunky A, Herrmann W, Kostner K.

Nephrol Dial Transplant. 2003 Aug;18(8):1568-72.

PMID:
12897096
22.

Effect of gastric banding on aminoterminal pro-brain natriuretic peptide in the morbidly obese.

Hanusch-Enserer U, Hermann KM, Cauza E, Spak M, Mähr B, Dunky A, Rosen HR, Köller U, Prager R.

Obes Res. 2003 Jun;11(6):695-8.

23.

Intravenous anti TNF-alpha antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis.

Cauza E, Cauza K, Hanusch-Enserer U, Etemad M, Dunky A, Kostner K.

Wien Klin Wochenschr. 2002 Dec 30;114(23-24):1004-7.

PMID:
12635469
24.

Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding.

Hanusch-Enserer U, Cauza E, Spak M, Dunky A, Rosen HR, Wolf H, Prager R, Eibl MM.

Int J Obes Relat Metab Disord. 2003 Mar;27(3):355-61.

PMID:
12629563
25.

Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab.

Cauza E, Spak M, Cauza K, Hanusch-Enserer U, Dunky A, Wagner E.

Rheumatol Int. 2002 Nov;22(6):227-32. Epub 2002 Sep 4.

PMID:
12426660
26.

Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.

Machold KP, Stamm TA, Eberl GJ, Nell VK, Dunky A, Uffmann M, Smolen JS.

J Rheumatol. 2002 Nov;29(11):2278-87.

PMID:
12415582
27.

Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu's arteritis.

Haberhauer G, Kittl EM, Dunky A, Feyertag J, Bauer K.

Clin Exp Rheumatol. 2001 Jul-Aug;19(4):477-8. No abstract available.

PMID:
11491512
28.

[Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A].

Feyertag J, Haberhauer G, Skoumal M, Kittl EM, Bauer K, Dunky A.

Acta Med Austriaca. 2000;27(5):156-9. German.

PMID:
11261266
29.

Interaction of monocytes from patients with psoriatic arthritis with cultured microvascular endothelial cells.

Neumüller J, Dunky A, Burtscher H, Jilch R, Menzel JE.

Clin Immunol. 2001 Jan;98(1):143-52.

PMID:
11141337
30.

Joint hypermobility syndrome and bilateral total occlusion of the ulnar arteries presenting as Raynaud's phenomenon.

Haberhauer G, Feyertag J, Hanusch-Enserer U, Dunky A.

Clin Exp Rheumatol. 2000 Mar-Apr;18(2):270-1. No abstract available.

PMID:
10812513
31.

[IgA rheumatoid factor and prognosis in chronic polyarthritis].

Wagner E, Hofmann E, Feyertag J, Dunky A.

Wien Med Wochenschr. 1999;149(19-20):548-9. German.

PMID:
10637964
32.

T cell derived cytokines in psoriatic arthritis synovial fluids.

Partsch G, Wagner E, Leeb BF, Bröll H, Dunky A, Smolen JS.

Ann Rheum Dis. 1998 Nov;57(11):691-3.

33.

Soluble CD44-isoform variant-5 (sCD44v5) in psoriatic arthritis.

Haberhauer G, Kittl EM, Bauer K, Skoumal M, Feyertag J, Dunky A.

Clin Exp Rheumatol. 1998 Nov-Dec;16(6):766-7. No abstract available.

PMID:
9844784
34.

Decisive diagnosis of seronegative polyarthritis by 3-phase bone scintigraphy.

Mirzaei S, Wagner E, Knoll P, Dunky A, Köhn H.

Nuklearmedizin. 1998;37(7):254-6.

PMID:
9830617
35.

[Value of inflammation and bone scintigraphy in differential diagnosis of painful affections of small joints].

Warchol O, König B, Dworak E, Köhn H, Dunky A, Mostbeck A.

Acta Med Austriaca. 1998;25(1):7-12. German.

PMID:
9576018
36.

Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.

Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen JS.

J Rheumatol. 1998 Jan;25(1):105-10.

PMID:
9458212
37.

Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells.

Dunky A, Neumüller J, Menzel J.

Clin Immunol Immunopathol. 1997 Dec;85(3):297-314.

PMID:
9400630
38.

Determination of HLA-B27 by enzyme immunoassay and flow cytometry: comparison with the classic microlymphocytotoxic assay.

Dunky A, Neumüller J, Wagner E, Hübner C, Bayer PM, Schwartz DW, Mayr WR.

Ann Clin Biochem. 1997 Mar;34 ( Pt 2):199-201. No abstract available.

PMID:
9133257
39.

Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid.

Partsch G, Steiner G, Leeb BF, Dunky A, Bröll H, Smolen JS.

J Rheumatol. 1997 Mar;24(3):518-23.

PMID:
9058659
40.

Therapeutic results with Cerebrolysin in the treatment of dementia.

Rainer M, Brunnbauer M, Dunky A, Ender F, Goldsteiner H, Holl O, Kotlan P, Paulitsch G, Reiner C, Stössl J, Zachhuber C, Mössler H.

Wien Med Wochenschr. 1997;147(18):426-31.

PMID:
9408984
41.

Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis.

Haberhauer G, Kittl EM, Skoumal M, Hübl W, Wagner E, Bayer PM, Bauer K, Dunky A.

Acta Med Austriaca. 1997;24(1):23-5.

PMID:
9150806
42.

HLA-B27 determination using serological methods. A comparison of enzyme immunoassay and a microlymphocytotoxic test with flow cytometry and a molecular biological assay.

Dunky A, Neumüller J, Hübner C, Fischer GF, Bayer PM, Wagner E, Schwartz DW, Mayr WR.

Rheumatol Int. 1996;16(3):95-100.

PMID:
8893373
43.

High free and latent collagenase activity in psoriatic arthritis synovial fluids.

Partsch G, Petera P, Leeb B, Meretey K, Koo E, Dunky A, Bröll H, Zamani O, Fertschak W, Matucci-Cerinic M, et al.

Br J Rheumatol. 1994 Aug;33(8):702-6.

PMID:
7519955
44.

Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac.

Kurowski M, Dunky A.

Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):479. No abstract available.

PMID:
1490791
45.

Complement C3 cleavage product in synovial fluids detected by immunofixation.

Partsch G, Bauer K, Bröll H, Petera P, Dunky A, Merétey K.

Z Rheumatol. 1991 Mar-Apr;50(2):82-5.

PMID:
1872046
46.

Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid.

Partsch G, Schwarzer C, Neumüller J, Dunky A, Petera P, Bröll H, Ittner G, Jantsch S.

Z Rheumatol. 1989 May-Jun;48(3):123-8.

PMID:
2551105
47.
48.

Methotrexate serum-level determinations during low-dose therapy of rheumatoid and psoriatic arthritis.

Leeb B, Dunky A, Ogris E, Wohanka A, Schenk G, Gaismayer K, Eberl R.

Int J Clin Pharmacol Res. 1989;9(3):209-15.

PMID:
2545638
49.

Autoimmunity and T-cell subpopulations in old age.

Menzel EJ, Zlabinger GJ, Dunky A, Steffen C.

Arch Gerontol Geriatr. 1988 Dec;7(4):249-60.

PMID:
2976265
50.

Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.

Chang T, Black A, Dunky A, Wolf R, Sedman A, Latts J, Welling PG.

J Antimicrob Chemother. 1988 Feb;21 Suppl B:49-56.

PMID:
3162901

Supplemental Content

Support Center